Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
Regulatory planning and development assessment encompass a coordinated suite of methodologies aimed at evaluating the impact, efficiency and equity of planning policies and regulatory interventions.
developmental assessments, therapy, ongoing care, and case management. Children we assess may have a developmental need or concern. They may also have characteristics of: Autism spectrum disorder, ...
Kenya introduces World Health Organization (WHO) child development assessment tool in national health survey for the first time ...
The Center for Global Education has resources on program development and assessment for educators, administrators, and those currently developing both formal and nonformal learning opportunities. We ...
Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment
Adoption of new cancer drugs requires careful consideration of their benefits, toxicities, and costs. Patient experiences are rarely considered in trial design and drug-approval processes. Challenges ...
It is important to consider such factors, discussed above, as type of R&D organization, type of assessment, and timescale of the assessment, so that the assessment of technical quality can be ...
McMaster University provides funding as a founding partner of The Conversation CA. McMaster University provides funding as a member of The Conversation CA-FR. Teachers’ perceptions and judgments of ...
Research and development (R&D) organizations are operated by government, business, academe, and independent institutes. The success of their parent organizations is closely tied to the success of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results